Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.37 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2721972 | 0.92 | SMN1; SMN2 (0.41) | SMN1; SMN2LMNAHTTNPC1RAB9A | |
| SCHEMBL211778 | 0.92 | PDCD1 (0.40) | SMN1; SMN2LMNAHTTNPC1RAB9A | |
| SCHEMBL211285 | 0.90 | PDCD1 (0.39) | SMN1; SMN2LMNAHTTNPC1RAB9A | |
| SCHEMBL210652 | 0.89 | RAB9A (0.44) | SMN1; SMN2LMNAHTTNPC1RAB9A | |
| SCHEMBL2721906 | 0.88 | KMT2A (0.44) | SMN1; SMN2LMNAHTTNPC1RAB9A | |
| SCHEMBL212594 | 0.87 | EPHX2 (0.42) | SMN1; SMN2LMNANPC1RAB9AALDH1A1 | |
| SCHEMBL2721313 | 0.87 | NPC1 (0.40) | SMN1; SMN2LMNANPC1RAB9AALDH1A1 | |
| SCHEMBL2721312 | 0.87 | NPC1 (0.40) | SMN1; SMN2LMNANPC1RAB9AALDH1A1 | |
| SCHEMBL2721934 | 0.86 | HIF1A (0.44) | SMN1; SMN2LMNANPC1RAB9APDCD1 | |
| SCHEMBL212356 | 0.86 | EPHX2 (0.43) | SMN1; SMN2LMNANPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120135964-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | QIAN XIANGPING (US) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135964-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | MYLK, MYH2, MYH10 | SMN1; SMN2 252/4885LMNA 216/4885HTT 1845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.